SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES

G. Schett; X. Baraliakos; F. van den Bosch; A. Deodhar; L. S. Gensler; Mikkel Østergaard; S. Agawane; A. D. Gupta; S. Mpofu; T. Fox; A. Winseck; A. Shete; B. Porter

SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES

G. Schett, X. Baraliakos, F. van den Bosch, A. Deodhar, L. S. Gensler, Mikkel Østergaard, S. Agawane, A. D. Gupta, S. Mpofu, T. Fox, A. Winseck, A. Shete, B. Porter

Afdeling for Rygkirurgi, Led- og Bindevævssygdomme

Originalsprog	Engelsk
Artikelnummer	FRI0380
Tidsskrift	Annals of the Rheumatic Diseases
Vol/bind	78
Udgave nummer	Suppl. 2
Sider (fra-til)	873-874
Antal sider	2
ISSN	0003-4967
Status	Udgivet - 2019

Citationsformater

Schett, G., Baraliakos, X., van den Bosch, F., Deodhar, A., Gensler, L. S., Østergaard, M., Agawane, S., Gupta, A. D., Mpofu, S., Fox, T., Winseck, A., Shete, A., & Porter, B. (2019). SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES. Annals of the Rheumatic Diseases, 78(Suppl. 2), 873-874. [FRI0380].

SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES. / Schett, G.; Baraliakos, X.; van den Bosch, F. et al.

I: Annals of the Rheumatic Diseases, Bind 78, Nr. Suppl. 2, FRI0380, 2019, s. 873-874.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Schett, G, Baraliakos, X, van den Bosch, F, Deodhar, A, Gensler, LS, Østergaard, M, Agawane, S, Gupta, AD, Mpofu, S, Fox, T, Winseck, A, Shete, A & Porter, B 2019, 'SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES', Annals of the Rheumatic Diseases, bind 78, nr. Suppl. 2, FRI0380, s. 873-874.

@article{2418b91a28c4404897fc64b15e079540,

title = "SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES",

author = "G. Schett and X. Baraliakos and {van den Bosch}, F. and A. Deodhar and Gensler, {L. S.} and Mikkel {\O}stergaard and S. Agawane and Gupta, {A. D.} and S. Mpofu and T. Fox and A. Winseck and A. Shete and B. Porter",

note = "COPECARE",

year = "2019",

language = "English",

volume = "78",

pages = "873--874",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 2",

}

TY - ABST

T1 - SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES

AU - Schett, G.

AU - Baraliakos, X.

AU - van den Bosch, F.

AU - Deodhar, A.

AU - Gensler, L. S.

AU - Østergaard, Mikkel

AU - Agawane, S.

AU - Gupta, A. D.

AU - Mpofu, S.

AU - Fox, T.

AU - Winseck, A.

AU - Shete, A.

AU - Porter, B.

N1 - COPECARE

PY - 2019

Y1 - 2019

M3 - Conference abstract in journal

VL - 78

SP - 873

EP - 874

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 2

M1 - FRI0380

ER -